Matthew Cooper: Clinical Trials

1 trial sponsored by Matthew Cooper, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Matthew Cooper: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
Everolimus, Tacrolimus, Mycophenolate mofetil (MMF/MPA) - Delayed Graft Function
Phase 2 / Phase 3TerminatedMatthew Cooper252013-06-012019-04-26

Conditions studied

Delayed Graft Function (1)  ·  Renal Insufficiency (1)

Interventions

Everolimus (1)  ·  Mycophenolic Acid (1)  ·  Tacrolimus (1)

Countries

United States (1)